Neuroendocrine dedifferentiation of a prostate adenocarcinoma after hormonal treatment - A case study

Acta Endocrinologica

Volumn 7, Issue 4, 2011, Pages 535-543

  Dema, A ^a   Taban, S ^b   Borda, A ^c   Lazurcanu, C ^a   Murcsan, A ^a   Cornianu, M ^a   Lazar, E ^a   Herman, D ^b   Onct, D ^b   Popovici, D ^d  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b Clinical Emergency County Hospital Pius Brinzeu Timisoara   (Romania)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d Obstetrics Gynecology Clinic   (Romania)

Author keywords

Androgen deprivation therapy; Metastases; Neuroendocrine dediffcrcntiation; Prostate cancer

Indexed keywords

EID: 84863624846     PISSN: 18410987     EISSN: None     Source Type: Journal    
DOI: 10.4183/aeb.2011.535     Document Type: Article

References (28)

1. Di Sant'Agnesc PA, de Mesy Jensen KL. Endocrine-paracrine cells of the prostate and prostatic urethra: an ultrastructural study. Hum Pathol 1984, 15: 11: 1034-1041. (Pubitemid 15130810)
2. Prcll K. Zur fragc der endokrinic dcr mcnschlichcn vorsteherdrusc. Virchows Arch. A. Pathol. Anat. Histopathol 1944; 312: 392-404.
3. Di Sant'Agnesc. PA. Neuroendocrine differentiation in human prostatic carcinoma. Hum Pathol 1992; 23: 287-296.
4. Abrahamsson PA. Neuroendocrine differentiation in prostate adenocarcinoma. Prostate 1999; 39: 135-148.
5. Di Sant'Agnesc PA. Neuroendocrine differentiation in prostate carcinoma: an update on recent developments. Ann Oncol 2001; 12(Suppl 2): S135-140.
6. Deftos LJ, Nakada S, Burton DW, diSant'Agnesc PA, Cockctt AT, Abrahamsson PA. Immunoassay and immunohistology studies of chromogranin A as a neuroendocrine marker in patients with carcinoma of the prostate. Urology 1996; 48: 58-62. (Pubitemid 26255959)
7. Bollito E, BciTuti A, Bcllina M, Mosca A, Leonardo E, Tarabuzzi R, Cappia S, Mari M, Tampcllini M, Fontana D. Relationship between neuroendocrine features and prognostic parameters in human prostate adenocarcinoma. Ann Oncol 2001; 12 (Suppl2):S159-S164. (Pubitemid 33069707)
8. Dema A, Raica M, Tudosc N. Prognostic significance of neuroendocrine differentiation in carcinoma of the prostate. Rom J Morphol Embryol, 1996, 42 (1-2): 83-88.
9. Yuan TC, Veeramani S, Lin FF, Kondrikou D, Zeliviansky S, Igawa T, Karan D, Batra SK, Lin MF. Androgen deprivation induces human prostate epithelial neuroendocrine differentiation of androgen-scnsitivc LNCaP cells. Endocr Rclat Cancer 2006; 13(1): 151-167.
10. Roudier MP, True LD, Vcssella RL, Higano CS. Metastatic conventional prostatic adenocarcinoma with diffuse chromogranin A and androgen receptor positivity. J Clin Pathol 2004; 57: 321-323. (Pubitemid 38338851)
11. Kincbuchi Y, Noguchi W, Irie K, Nakayama T, Kalo H, Nishizawa O. Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostate-specific antigen. A case report. Int J Urol 2007; 14: 147-149. (Pubitemid 46121953)
12. Yamamoto N, Kinoshila H, Inoue T, Kawakita S, Oguchi N, Mugurula K, Kawa G, Sakaguchi Y, Adaehi Y, Sakaida N, Ucmura Y, Matsuda T. Small cell carcinoma of the prostate: a case report Hinyokika Kiyo 2007: 53 (9): 665-669
13. Segawa N, Inamoto T, Ibuki N, Mizutani Y, Azuma H, Tsuji M, Katsuoka Y. Neuroendocrine differentiation in adenocarcinoma of the prostate during hormonal treatment : a case report. Hinyokika Kiyo 2010; 56 (1): 49-54.
14. Nemoto K, Tateishi T, Ishidate T. Changes in diffusion-weighted images for visualizing prostate cancer during antiandrogen therapy: preliminary results. Urol Int 2010; 85 (4): 421-426.
15. Epstein JI, Netto GJ. Neuroendocrine differentiation in the benign and malignant prostate. In: Epstein JI, Netto GJ. Biopsy interpretation of the prostate. 4th Ed, Philadelphia: Lippincott Williams & Wilkins, 2008: 228-237.
16. Berruti A, Dogliotti L, Mosca A, Gorzegano G, Bollito E, Mari M, Tarabuzzi R, Poggio M, Torta M, Fontana D, Angeli A. Potential clinical value of circulating chromogranin A in patients with prostate carcinoma. Ann Oncol 2001; 12 (Suppl 2):S153-157. (Pubitemid 33069706)
17. Trotz C. Prostate Cancer with a Normal PSA: Small Cell Carcinoma of the Prostate - A Rare Entity. J Am Board Fam Pract 2003; 16:343-344.
18. Ordonez NG. Value of thyroid transcription factor-1 immunostaining in distinguishing small cell lung carcinomas from other small cell carcinomas. Am J Surg Pathol 2000; 24: 1217-1223.
19. Agoff NS, Lamps LW, Philip AT, Amin MB, Schmidt RA, True LD, Folpe AL. Thyroid Transcription Factor-1 is expressed in extrapulmonary small cell carcinoma but not in other extrapulmonary neuroendocrine tumors. Mod Pathol 2000; 13(3): 238-242). (Pubitemid 30207508)
20. Yao JL, Madeb R, Bourne P, Lei J, Yang X, Tickoo S, Liu Z, Tan D, Cheng L, Hatcm F, Huang J, Anthony di Sant'Agncsc P. Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol 2006; 30: 705-712 (Pubitemid 44264995)
21. Wang W, Epstein JI. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008; 32( 1): 65-71.
22. Feuer JA, Lush RM, Vcnzon D, Duray P, Tompkins A, Sartor O, Figg WD. Elevated carcinoembryonic antigen in patients with androgen - independent prostate cancer. J Inveslig Med 1998; 46(2): 66-72. (Pubitemid 128452771)
23. Sella A, Konichezky M, Flex D, Sulkes A, Baniel J. Low PSA metastatic androgen - independent prostate cancer. Eur Urol 2000; 38(3): 250-254. (Pubitemid 30665949)
24. Rubenstein JH, Katin MJ, Mangano MM, Dauphin J, Salcnius SA, Dosoretz DE, Blitzer PH. Small cell anaplastic carcinoma of the prostate: seven cases, review of the literature, and discussion of a therapeutic strategy. Am J Clin Oncol 1997; 20: 376-80. (Pubitemid 27329571)
25. Simon RA, Di'Sant Agncse PA, Huang LS, Xu H, Yao JL, Yang O, Liang S, Liu J, Yu R, Cheng L, Oh WK, Palapaltou GS, Wei J, Huang J. CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. Hum Pathol 2009; 40(2): 252-258.
26. Evans AJ, Humphrey PA, Belani J, Van der Kwast Th, Sriglcy JR. Large cell neuroendocrine carcinoma of prostate: a chnicopathoiogic summary of 7 cases of a rare manifestation of advanced prostate cancer. Am J Surg Pathol 2006; 30(6): 684-693. (Pubitemid 44264993)
27. Spicss PE, Pcttaway CA, Vakar-Lopez F, Kassoufw W, Wang X, Busby JE. Do KA, Davuluri R, Tannir NM. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer 2007; 110(8): 1729-1737. (Pubitemid 47557297)
28. Aygun C. Small cell carcinoma of the prostate: a case report and review of the literature. Md Med J 1997; 46: 353-356.